Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Insulinoma 2Nesidioblastosis 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 224Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 194camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119toripalimab 118Radiosurgery 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108S 1 (combination) 105anlotinib 104Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × 68Ga-NOTA-exendin-4 × Clear all
NCT04979611 2023-09-21

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

First Affiliated Hospital of Fujian Medical University

Phase 1 Unknown
60 enrolled
Endocrine

Insulinoma

NCT02560376 2015-09-25

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
Endocrine

Insulinoma, Nesidioblastosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡